Insider · CIK 0001520061

Beraud Jill

Reports to the SEC for 4 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001520061

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-05	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+92 sh	—	—	14,463
2026-08-05	LEVILEVI STRAUSS & COA Award	Director	AAward	+54 sh	—	—	181,261
2026-05-06	LEVILEVI STRAUSS & COA Award	Director	AAward	+50 sh	—	—	181,207
2026-05-06	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+86 sh	—	—	14,371
2026-04-22	LEVILEVI STRAUSS & COA Award	Director	AAward	+8,381 sh	—	—	181,157
2026-02-25	LEVILEVI STRAUSS & COA Award	Director	AAward	+75 sh	—	—	172,776
2026-02-25	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+89 sh	—	—	14,285
2025-11-04	LEVILEVI STRAUSS & COA Award	Director	AAward	+85 sh	—	—	172,701
2025-11-04	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+101 sh	—	—	14,196
2025-08-08	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+97 sh	—	—	14,095
2025-08-08	LEVILEVI STRAUSS & COA Award	Director	AAward	+82 sh	—	—	172,616
2025-05-09	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+104 sh	—	—	13,998
2025-05-09	LEVILEVI STRAUSS & COA Award	Director	AAward	+88 sh	—	—	172,534
2025-04-23	LEVILEVI STRAUSS & COC Conversion	Director	CConversion	+109K sh	—	—	160,756
2025-04-23	LEVILEVI STRAUSS & COA Award	Director	AAward	+11.7K sh	—	—	172,446
2025-04-23	LEVILEVI STRAUSS & CO · Class B Common StockC Conversion	Director	CConversion	−109K sh	—	—	13,894
2025-02-28	LEVILEVI STRAUSS & COA Award	Director	AAward	+56 sh	—	—	52,077
2025-02-28	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+99 sh	—	—	122,573
2025-02-06	Revance Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-02-04	Revance Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−28.6K sh	$3.65	−$104K	15,000
2024-11-14	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+106 sh	—	—	122,474
2024-11-14	LEVILEVI STRAUSS & COA Award	Director	AAward	+60 sh	—	—	52,021
2024-08-20	LEVILEVI STRAUSS & COA Award	Director	AAward	+52 sh	—	—	51,961
2024-08-20	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+93 sh	—	—	122,368
2024-05-23	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+74 sh	—	—	122,275
2024-05-23	LEVILEVI STRAUSS & COA Award	Director	AAward	+42 sh	—	—	51,909
2024-05-01	Revance Therapeutics, Inc.A Award	Director	AAward	+15K sh	—	—	43,606
2024-05-01	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+23.5K sh	—	—	23,458
2024-04-24	LEVILEVI STRAUSS & COA Award	Director	AAward	+7,642 sh	—	—	51,867
2024-02-23	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+88 sh	—	—	122,201
2024-02-23	LEVILEVI STRAUSS & COA Award	Director	AAward	+69 sh	—	—	44,225
2023-11-09	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+112 sh	—	—	122,113
2023-11-09	LEVILEVI STRAUSS & COA Award	Director	AAward	+87 sh	—	—	44,156
2023-08-17	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+113 sh	—	—	122,001
2023-08-17	LEVILEVI STRAUSS & COA Award	Director	AAward	+88 sh	—	—	44,069
2023-05-18	LEVILEVI STRAUSS & COA Award	Director	AAward	+129 sh	—	—	43,981
2023-05-18	LEVILEVI STRAUSS & CO · Class B Common StockA Award	Director	AAward	+117 sh	—	—	121,888
2023-05-03	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+5,915 sh	—	—	5,915
2023-05-03	Revance Therapeutics, Inc.A Award	Director	AAward	+3,534 sh	—	—	28,606
2023-04-19	LEVILEVI STRAUSS & COA Award	Director	AAward	+10.3K sh	—	—	43,852
2023-02-23	LEVILEVI STRAUSS & COA Award	Director	AAward	+81 sh	—	—	77,962
2023-02-23	LEVILEVI STRAUSS & COA Award	Director	AAward	+87 sh	—	—	77,707
2022-11-21	LEVILEVI STRAUSS & COA Award	Director	AAward	+190 sh	—	—	77,794
2022-08-17	LEVILEVI STRAUSS & COA Award	Director	AAward	+152 sh	—	—	77,604
2022-05-24	LEVILEVI STRAUSS & COA Award	Director	AAward	+222 sh	—	—	77,452
2022-05-04	Revance Therapeutics, Inc.A Award	Director	AAward	+6,059 sh	—	—	25,072
2022-05-04	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,343
2022-05-04	Revance Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,756
2022-04-20	LEVILEVI STRAUSS & COA Award	Director	AAward	+7,812 sh	—	—	77,230
2022-02-24	LEVILEVI STRAUSS & COA Award	Director	AAward	+129 sh	—	—	69,418

Recent filings

Accepted (ET)
Aug 74
Beraud Jill0001999371-26-017422
SEC(opens sec.gov)
May 84
Beraud Jill0001999371-26-010380
SEC(opens sec.gov)
Apr 244
Beraud Jill0001999371-26-009019
SEC(opens sec.gov)
Feb 274
Beraud Jill0001999371-26-004640
SEC(opens sec.gov)
Nov 64
Beraud Jill0001999371-25-017124
SEC(opens sec.gov)
Aug 124
Beraud Jill0001999371-25-011151
SEC(opens sec.gov)
May 124
Beraud Jill0001999371-25-005903
SEC(opens sec.gov)
Apr 254
Beraud Jill0001999371-25-004779
SEC(opens sec.gov)
Mar 44
Beraud Jill0001839882-25-013573
SEC(opens sec.gov)
Feb 64
Beraud Jill0000950170-25-015341
SEC(opens sec.gov)

Companies

Address

C/O LEVI STRAUSS & CO. 1155 BATTERY STREET

SAN FRANCISCO, CA, 94111